4th Quarter - Termination

MCDERMOTT+ LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING

Firm
Client
Income
$30,000
Expenses
—
Terminated
Dec 31, 2023

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Prescription drug pricing issues. Implementation of the Inflation Reduction Act - Public Law No 117-69. H.R. 485 - the Protecting Health Care for All Patients Act.

LobbyistCovered position, as disclosed
RODNEY WHITLOCK 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 485 (118th)

Pharmacy PHA

Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.

LobbyistCovered position, as disclosed
RODNEY WHITLOCK 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 1067 (118th), S. 935 (118th), S. 1214 (118th), S. 775 (118th), H.R. 485 (118th)

Copyright/Patent/Trademark CPT

Patent abuse issues. S. 150 - Affordable Prescriptions for Patients Act of 2023. S. 79 - Interagency Patent Coordination Act. Initiatives To Ensure the Robustness and Reliability of Patents Rights (PTO-P-2022-0025). Joint USPTO-FDA Collaboration Initiatives.

LobbyistCovered position, as disclosed
RODNEY WHITLOCK 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 150 (118th), S. 79 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.